Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances
Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances Study results highlight the Company's Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform for characterization of Alzheimer's Disease PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Platform. The study appeared ...
Source: finanznachrichten.de